NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

23andMe Holding Co. Class A Common Stock (NASDAQ: ME)

 
ME Technical Analysis
5
As on 9th Jun 2023 ME STOCK Price closed @ 1.93 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.66 & Strong Sell for SHORT-TERM with Stoploss of 5.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MESTOCK Price

Open 1.98 Change Price %
High 2.04 1 Day -0.08 -3.98
Low 1.92 1 Week -0.15 -7.21
Close 1.93 1 Month -0.04 -2.03
Volume 3026275 1 Year -5.21 -72.97
52 Week High 7.43 | 52 Week Low 1.87
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ME
Daily Charts
ME
Intraday Charts
Whats New @
Bazaartrend
ME
Free Analysis
 
ME Important Levels Intraday
RESISTANCE2.16
RESISTANCE2.09
RESISTANCE2.04
RESISTANCE2.00
SUPPORT1.86
SUPPORT1.82
SUPPORT1.77
SUPPORT1.70
 
ME Forecast May 2024
4th UP Forecast7.38
3rd UP Forecast5.63
2nd UP Forecast4.55
1st UP Forecast3.47
1st DOWN Forecast0.39
2nd DOWN Forecast-0.69
3rd DOWN Forecast-1.77
4th DOWN Forecast-3.52
 
ME Weekly Forecast
4th UP Forecast3.95
3rd UP Forecast3.30
2nd UP Forecast2.90
1st UP Forecast2.50
1st DOWN Forecast1.36
2nd DOWN Forecast0.96
3rd DOWN Forecast0.56
4th DOWN Forecast-0.09
 
ME Forecast2024
4th UP Forecast13.11
3rd UP Forecast9.52
2nd UP Forecast7.31
1st UP Forecast5.09
1st DOWN Forecast-1.23
2nd DOWN Forecast-3.45
3rd DOWN Forecast-5.66
4th DOWN Forecast-9.25
 
 
ME Other Details
Segment EQ
Market Capital 4596681728.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
ME Address
ME
 
ME Latest News
 
Your Comments and Response on 23andMe Holding Co. Class A Common Stock
 
ME Business Profile
23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize promising drugs. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. The company was founded in 2006 and is headquartered in Sunnyvale, California. Address: 223 North Mathilda Avenue, Sunnyvale, CA, United States, 94086
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service